Key result
Underweight patients undergoing total shoulder arthroplasty had higher odds of any 30-day perioperative adverse event compared to normal-weight patients (OR 2.22; P=0.034).
Why the study?
Existing literature on BMI and surgical complications has focused on elevated BMI with mixed results, while few studies have evaluated complications in low-BMI patients.
Does being underweight increase the risk of 30-day perioperative adverse events in patients undergoing elective total shoulder arthroplasty compared to normal weight?
Cohort (n=15,717)
Yes
Does being underweight increase the risk of 30-day perioperative adverse events in patients undergoing elective total shoulder arthroplasty compared to normal weight?
Odds Ratio: 2.22
p-value: p=0.034
Underweight patients undergoing total shoulder arthroplasty represent a fragile cohort with significantly higher rates of 30-day perioperative adverse events compared to normal-weight patients.
May warrant closer perioperative monitoring in underweight patients; hypothesis-generating for preoperative optimization trials.
INTRODUCTION: Existing literature investigating the correlation of body mass index (BMI) with surgical complications has focused on those with elevated BMI. These investigations have reported mixed conclusions, possible because of insufficient power, poor controlling of confounding variables, and inconsistent definitions of BMI categories (eg, underweight, overweight, and varying classifications of obese). Few studies have considered complications of patients with low BMI. The aim of the current study was to analyze the spectrum of categories for BMI with 30-day perioperative adverse events after primary total shoulder arthroplasty (TSA) to better assess where along the BMI spectrum patients are at risk for complications. METHODS: Patients undergoing elective TSA were abstracted from the National Surgical Quality Improvement Program (NSQIP) databases from 2005 to 2016. Patients were then aggregated into BMI categories, and 30-day adverse events were normalized to average risk of normal-weight subjects (BMI 18.5 to 24.9 kg/m2). Risk-adjusted multivariate regressions were performed, controlling for demographic variables and overall health. RESULTS: In total, 15,717 patients met the inclusion criteria. Underweight TSA patients (BMI < 18.5 kg/m2) had the greatest odds for multiple perioperative adverse events compared with any other BMI category. By multivariate analysis, underweight patients were more likely to experience any adverse event (odds ratio [OR] = 2.22, P = 0.034), serious adverse events (OR = 3.18, P = 0.004), or have postoperative infections (OR = 2.77, P = 0.012) within 30 days when compared with normal-weight patients. No significant difference was observed in these complications for elevated BMI categories when compared with normal-weight patients. CONCLUSIONS: Only underweight TSA patients were found to have higher rates of 30-day perioperative adverse events than normal BMI patients, unlike any overweight/obese category including the super morbidly obese. Underweight TSA patients were thus identified as an at-risk subpopulation of TSA patients who had not previously been described. Physicians and healthcare systems should give additional consideration to this fragile cohort because they often already do for those at the other end of the BMI spectrum. LEVEL OF EVIDENCE: III.
No takes yet. Share an insight, caveat, or question.
Ottesen et al. (2020) conducted a cohort in Elective total shoulder arthroplasty (TSA) (n=15,717). Underweight (BMI < 18.5 kg/m2) vs. Normal-weight patients (BMI 18.5 to 24.9 kg/m2) was evaluated on Any adverse event within 30 days (OR 2.22, p=0.034). Underweight patients undergoing total shoulder arthroplasty had higher odds of any 30-day perioperative adverse event compared to normal-weight patients (OR 2.22; P=0.034).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: